The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Walker Neal since year 2005.
The trader's CIK number is 1604457.
At the time of this reporting, Walker Neal is the President and CEO of Aclaris Therapeutics, Inc. .
(stock ticker symbol ACRS).
See this page for all insider trading activities at Aclaris Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-05-07||ACRS||Aclaris Therapeutics, Inc.||Option Ex||12,133||.00||0|
|2018-04-05||ACRS||Aclaris Therapeutics, Inc.||Buy||10,000||16.75||167,500|
|2017-12-15||ACRS||Aclaris Therapeutics, Inc.||Option Ex||3,033||.00||0|
|2017-12-18||ACRS||Aclaris Therapeutics, Inc.||Option Ex||2,925||.00||0|
|2016-12-18||ACRS||Aclaris Therapeutics, Inc.||Option Ex||2,925||.00||0|
|2014-05-07||ALDX||Aldeyra Therapeutics, Inc.||Buy||6,250||8.00||50,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Walker Neal (President and CEO of Aclaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.